PMID- 28699511 OWN - NLM STAT- MEDLINE DCOM- 20171106 LR - 20180816 IS - 1875-5550 (Electronic) IS - 1389-2037 (Linking) VI - 18 IP - 11 DP - 2017 Aug 30 TI - Striatal-enriched Tyrosine Protein Phosphatase (STEP) in the Mechanisms of Depressive Disorders. PG - 1152-1162 LID - 10.2174/1389203718666170710121532 [doi] AB - Striatal-enriched tyrosine protein phosphatase (STEP) is expressed mainly in the brain. Its dysregulation is associated with Alzheimer's and Huntington's diseases, schizophrenia, fragile X syndrome, drug abuse and stroke/ischemia. However, an association between STEP and depressive disorders is still obscure. The review discusses the theoretical foundations and experimental facts concerning possible relationship between STEP dysregulation and depression risk. STEP dephosphorylates and inactivates several key neuronal signaling proteins such as extracellular signal-regulating kinase 1 and 2 (ERK1/2), stress activated protein kinases p38, the Src family tyrosine kinases Fyn, Pyk2, NMDA and AMPA glutamate receptors. The inactivation of these proteins decreases the expression of brain derived neurotrophic factor (BDNF) necessary for neurogenesis and neuronal survival. The deficit of BDNF results in progressive degeneration of neurons in the hippocampus and cortex and increases depression risk. At the same time, a STEP inhibitor, 8-(trifluoromethyl)-1,2,3,4,5-benzopentathiepin-6-amine hydrochloride (TC-2153), increases BDNF expression in the hippocampus and attenuated the depressivelike behavior in mice. Thus, STEP is involved in the mechanism of depressive disorders and it is a promising molecular target for atypical antidepressant drugs of new generation. CI - Copyright(c) Bentham Science Publishers; For any queries, please email at epub@benthamscience.org. FAU - Kulikova, Elizabeth AU - Kulikova E AD - Federal Research Center, Institute of Cytology and Genetics, Siberian Branch of Russian Academy of Sciences, 630090, Novosibirsk. Russian Federation. FAU - Kulikov, Alexander AU - Kulikov A AD - Federal Research Center Institute of Cytology and Genetics, Siberian Branch of Russian Academy of Sciences, 10 avenue Lavrentyev, 630090, Novosibirsk. Russian Federation. LA - eng PT - Journal Article PT - Review PL - United Arab Emirates TA - Curr Protein Pept Sci JT - Current protein & peptide science JID - 100960529 RN - 0 (8-(trifluoromethyl)-1,2,3,4,5-benzopentathiepin-6-amine) RN - 0 (Benzothiepins) RN - 0 (Brain-Derived Neurotrophic Factor) RN - 0 (Receptors, AMPA) RN - 0 (Receptors, N-Methyl-D-Aspartate) RN - 7171WSG8A2 (BDNF protein, human) RN - EC 2.7.- (Protein Kinases) RN - EC 2.7.10.2 (FYN protein, human) RN - EC 2.7.10.2 (Proto-Oncogene Proteins c-fyn) RN - EC 3.1.3.48 (PTPN5 protein, human) RN - EC 3.1.3.48 (Protein Tyrosine Phosphatases, Non-Receptor) SB - IM MH - Animals MH - Benzothiepins/pharmacology MH - Brain/drug effects/*enzymology/pathology MH - Brain-Derived Neurotrophic Factor/genetics/metabolism MH - Depression/drug therapy/enzymology/*genetics/physiopathology MH - Disease Models, Animal MH - Gene Expression Regulation MH - Humans MH - Mice MH - Neurons/drug effects/*enzymology/pathology MH - Phosphorylation MH - Protein Kinases/genetics/metabolism MH - Protein Tyrosine Phosphatases, Non-Receptor/antagonists & inhibitors/*genetics/metabolism MH - Proto-Oncogene Proteins c-fyn/genetics/metabolism MH - Receptors, AMPA/genetics/metabolism MH - Receptors, N-Methyl-D-Aspartate/genetics/metabolism MH - Signal Transduction OTO - NOTNLM OT - BDNF OT - NMDA receptors. OT - STEP OT - TC-2153 OT - antidepressant OT - depression OT - serotonin EDAT- 2017/07/13 06:00 MHDA- 2017/11/07 06:00 CRDT- 2017/07/13 06:00 PHST- 2017/05/07 00:00 [received] PHST- 2017/06/21 00:00 [revised] PHST- 2017/06/21 00:00 [accepted] PHST- 2017/07/13 06:00 [pubmed] PHST- 2017/11/07 06:00 [medline] PHST- 2017/07/13 06:00 [entrez] AID - CPPS-EPUB-84637 [pii] AID - 10.2174/1389203718666170710121532 [doi] PST - ppublish SO - Curr Protein Pept Sci. 2017 Aug 30;18(11):1152-1162. doi: 10.2174/1389203718666170710121532.